Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 49 for “"Biological therapy"”.

  1. Biological therapy in bronchial asthma: case reports /

    … study explores the potential of two promising biological therapies, benralizumab and omalizumab in specifically targeting this form of severe bronchial asthma. By exploring the therapeutic application, efficacy and clinical effectiveness of these agents, this research aims to empower healthcare …

    vilnius Repository record for Biological therapy in bronchial asthma: case reports / (opens in a new tab)

  2. Biological therapy for moderate-to-severe psoriasis: a 5-year analysis of patients from lithuania /

    … 76,000 patients in Lithuania (prevalence ~2%). Biological agents targeting tumour necrosis factor (TNF-α) and interleukins 12/23, 17, and 23 represent one of the principal systemic treatment options for moderate-to-severe psoriasis. Despite extensive international clinical trial and registry …

    vilnius Repository record for Biological therapy for moderate-to-severe psoriasis: a 5-year analysis of patients from lithuania / (opens in a new tab)

  3. The association between extraintestinal manifestations and sequential biological therapy in patients with inflammatory bowel disease

    … many patients will require the need to utilize biological therapies during their disease course. Moreover, some patients with IBD develop disease manifestations outside of the GI (gastrointestinal) tract termed extraintestinal manifestations (EIM). We sought to establish an association between …

    bu Repository record for The association between extraintestinal manifestations and sequential biological therapy in patients with inflammatory bowel disease (opens in a new tab)

  4. Sergančiųjų reumatoidiniu artritu, kuriems taikoma biologinė terapija, gyvenimo kokybės įvertinimas /

    … in Patient with Rheumatoid Arthritis Undergoing Biological Therapy The Author: student Greta Eidukonytė, nursing bachelor program at Vilnius University. Work Leader: Vilnius University Hospital Rheumatology senior nurse-administrator Jurga Šuminienė 2016-05-16 Work size: 54 Keywords: RA- …

    vilnius Repository record for Sergančiųjų reumatoidiniu artritu, kuriems taikoma biologinė terapija, gyvenimo kokybės įvertinimas / (opens in a new tab)

  5. Burdens and outcomes of paediatric-onset inflammatory bowel disease in regional, national and pan-UK cohorts

    … options also overlap; this includes the biological agents which inhibit TNF (anti-TNFα agents). Patients diagnosed in childhood and adolescence in most countries are cared for in paediatric services before moving to adult services at an appropriate time for lifelong care; this move is …

    edinburgh Repository record for Burdens and outcomes of paediatric-onset inflammatory bowel disease in regional, national and pan-UK cohorts (opens in a new tab)

  6. Sunki eozinofilinė astma. Klinikinis atvejis ir literatūros apžvalga /

    … precision medicine approach. The integration of biological therapy into severe asthma treatment algorithms has opened new opportunities for individualised care; however, challenges remain in clinical practice regarding the selection of the most appropriate biological agent and the decision to …

    vilnius Repository record for Sunki eozinofilinė astma. Klinikinis atvejis ir literatūros apžvalga / (opens in a new tab)

  7. Development of patient-centred outcomes in asthma and allergy

    … and evidenced definitions of response to biological therapy as outcomes for severe asthma. Forth, to develop composite response tools as standardised outcomes with input of patients to assess response to biological therapy for severe asthma.<br/>The results achieved with patient input …

    soton Download PDF for Development of patient-centred outcomes in asthma and allergy (opens in a new tab)

  8. Physical activity in daily life in patients with asthma and the effect of anti-interleukin-5 therapy

    … cohort of severe asthma patients, mepolizumab biological therapy conferred significant and meaningful improvements in PADL.

    greece Repository record for Physical activity in daily life in patients with asthma and the effect of anti-interleukin-5 therapy (opens in a new tab)

  9. Šiuolaikinis uždegiminių žarnų ligų gydymas. Indikacijos, kontraindikacijos biologinei terapijai, jos sukeliamos komplikacijos /

    … contraindications and complications of biological therapy for inflammatory bowel disease that are commonly reported in the scientific literature. Review of the literature: The selection for scientific publications was made from 2024 01 16 to 2024 03 20. Scientific publications were …

    vilnius Repository record for Šiuolaikinis uždegiminių žarnų ligų gydymas. Indikacijos, kontraindikacijos biologinei terapijai, jos sukeliamos komplikacijos / (opens in a new tab)

  10. Οξειδωτικό στρες και βιοδείκτες φλεγμονής στο άσθμα

    … control, but was reduced in those receiving IL-5 biological therapy. PAT showed marked variability, mainly related to comorbidities and adaptive antioxidant response. None of the biomarkers was reliably correlated with symptom control scores or spirometric indices. Conclusions:suPAR, d-ROM, and …

    greece Repository record for Οξειδωτικό στρες και βιοδείκτες φλεγμονής στο άσθμα (opens in a new tab)

  11. The experience of psoriatic arthritis patients receiving biological treatment : an interpretative phenomenological analysis

    The recent development of biological therapies has revolutionized medical treatment for psoriatic arthritis. To date, research studies have focused on the treatment effects of biologics from a quantitative perspective using generic quality of life measures. An understanding of how treatment with …

    london-metro Download PDF for The experience of psoriatic arthritis patients receiving biological treatment : an interpretative phenomenological analysis (opens in a new tab)

  12. Η παθογένεια της πυώδους ιδραδενίτιδας

    … to play an important role. There is no specific therapy for HS. Objective: To investigate the safety and efficacy of the anti-inflammatory biological therapy anakinra in HS.Design: Double-blind, randomized, placebo-controlled clinical trial with a 12-week treatment phase and a 12-week follow-up …

    greece Repository record for Η παθογένεια της πυώδους ιδραδενίτιδας (opens in a new tab)

  13. Vaikų multisisteminis uždegiminis sindromas, susijęs su SARS-CoV-2 infekcija: diagnostika ir gydymo išeitys /

    … of a positive effect, glucocorticoids and biological therapy are recommended. In many cases, during the acute phase deviating laboratory findings reach normal levels after prescribed treatment. ECG and echocardiogram changes normalise in the first 6 months after the acute phase in the …

    vilnius Repository record for Vaikų multisisteminis uždegiminis sindromas, susijęs su SARS-CoV-2 infekcija: diagnostika ir gydymo išeitys / (opens in a new tab)

  14. A Pilot Study of Primary Culture of Oral Epithelium using the Direct Explant Technique

    … produce bone. The potential use of MSC’s as a biological therapy has clinical applications for both dental and medical science.

    creighton Repository record for A Pilot Study of Primary Culture of Oral Epithelium using the Direct Explant Technique (opens in a new tab)

  15. ANTIBODIES TO INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: CLINICAL AND MOLECULAR TARGETS

    Infliximab was the first biological therapy to be approved for use in inflammatory bowel disease (IBD). Similar to other biological therapies, secondary loss of response to infliximab occurs in up to 50% of patients at 1 year follow up. In the case of infliximab, antibodies to infliximab (ATI) are …

    whiterose Download file for ANTIBODIES TO INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: CLINICAL AND MOLECULAR TARGETS (opens in a new tab)

Page 1 of 3